All
Breaking Down Treatment Options for Patients With Head and Neck Cancer
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
Going Off Medication for Lymphoma: Could It Be True?
After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly taking me off of it.
PROSTOX May Predict Urinary Side Effects Post Prostate Cancer Radiation
A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.
Early Intervention and Screening Prevents Lymphedema After Cancer
Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.
FDA Grants Positive Review for AML Drug Trial, First Dosing in 2025
The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.
Cardiometabolic Considerations for Childhood Cancer Survivors Explained
The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.
Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.
FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer
The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.
Sometimes Cancer is a (Welcome) Distraction
In an upside-down, topsy-turvy world, cancer can be a distraction for us.
SLS009 May Improve Survival in R/R AML
SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.
A Patient Shares Insights on Kidney Cancer Awareness and Advocacy
Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and patient advocacy.
Bavencio Has Long-Term Benefit Regardless of Diabetes Status in Bladder Cancer
Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.
Raising Awareness for Kidney Cancer and the Challenges Patients Face
It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.
How ‘Man in the Mirror’ Reflects a Cancer Journey
I always wanted to make a difference, but I never expected my biggest impact to come through cancer.
BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
How Biomarker Testing Can Shape a Breast Cancer Treatment Plan
Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.
Raising Awareness for Lymphedema Following a Cancer Diagnosis
Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.
FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Personalized Cancer Vaccine Generates Responses Across Cancer Types
PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer, as well as multiple myeloma.
Understanding the Use of Bispecific Antibodies in Multiple Myeloma
Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Overcoming Challenges and Advancing CAR-T Therapy for Myeloma
CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, despite strong efficacy in trials.
The Miniature Zen Garden: A Useful Tool for Those Dealing with Cancer
I tried using a Zen garden that helped me meditate and relax while dealing with the challenges of cancer, and it really works.
FDA Grants Breakthrough Therapy to IDE196 in Primary Uveal Melanoma
The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when enucleation has been recommended.
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.
Machine Learning Improves Transplant Risk Assessment in Myelofibrosis
Machine learning model improves transplant risk assessment for patients with myelofibrosis, helping clinicians make informed decisions, as per an expert.
Are You Worried About HER2+ Breast Cancer Recurrence?
Survey Findings Reveal Financial Challenges in Patients with Cancer
Among patients with cancer, high out-of-pocket costs were found to impact access to health care, adherence to medication, as well as quality of life.
